PDCD1 and neoplasm: This was followed by a shift from an immunosuppressive to a tumor-reactive TME, with increased CD3+ T cell infiltration and reduced Tim-3+ PD-1+ T cells and PD-L1 levels, highlighting the system ability to reverse T cell exhaustion following radiation.